Bach Mark Allen 4/A
4/A · Structure Therapeutics Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4/AAmended
Bach Mark Allen
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-15+65,352→ 65,352 totalExercise: $11.75Exp: 2034-03-14→ Ordinary Shares (65,352 underlying)
Footnotes (3)
- [F1]This amendment is being filed to correct the exercise price as that of the Ordinary Shares rather than the American Depositary Shares ("ADSs"). The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
- [F2]1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.
- [F3]The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.